Correction: Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo (European Journal of Immunology (1993) 23 9 (2226))

Correction: Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo (European Journal of Immunology (1993) 23 9 (2226))

Bibliographic Details
Main Authors:	Powrie, F, Menon, S, Coffman, R
Format:	Journal article
Language:	English
Published:	1994

Similar Items

INTERLEUKIN-4 AND INTERLEUKIN-10 SYNERGIZE TO INHIBIT CELL-MEDIATED-IMMUNITY IN-VIVO (VOL 23, PG 2226, 1993)
by: Powrie, F, et al.
Published: (1994)

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
by: Powrie, F, et al.
Published: (1993)

Interleukin-4 and interleukin-10 synergize to inhibit cell-mediated immunity in vivo.
by: Powrie, F, et al.
Published: (1993)

The interleukin-23 axis in intestinal inflammation.
by: Ahern, P, et al.
Published: (2008)

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
by: Asseman, C, et al.
Published: (1999)

Pharmacy (ISSN 2226-4787) — A Journal of Pharmacy Education and Practice
by: Keith A. Wilson, et al.
Published: (2013-02-01)

The Interleukin-23 / Interleukin-17 axis in intestinal inflammation.
by: Maloy, K
Published: (2008)

Interleukin-23 Inhibitors
by: Esra Adışen
Published: (2022-04-01)

An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation.
by: Asseman, C, et al.
Published: (1999)

Interleukin-23 drives intestinal inflammation through direct activity on T cells
by: Schiering, C, et al.
Published: (2010)

Interleukin-23 drives innate and T cell-mediated intestinal inflammation.
by: Hue, S, et al.
Published: (2006)

Interleukin-23 drives intestinal inflammation through direct activity on T cells
by: Ahern, P, et al.
Published: (2011)

Interleukin-23 drives intestinal inflammation through direct activity on T cells.
by: Ahern, P, et al.
Published: (2010)

Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology.
by: Buonocore, S, et al.
Published: (2010)

Interleukin-23 restrains regulatory T cell activity to drive T cell-dependent colitis.
by: Izcue, A, et al.
Published: (2008)

Interleukin-10 in the regulation of T cell-induced colitis.
by: Annacker, O, et al.
Published: (2003)

Overexpression of Interleukin-23 and Interleukin-17 in the Lesion of Pemphigus Vulgaris: A Preliminary Study
by: Jixin Xue, et al.
Published: (2014-01-01)

Dysregulated hematopoietic stem and progenitor cell activity promotes interleukin-23-driven chronic intestinal inflammation.
by: Griseri, T, et al.
Published: (2012)

Dysregulated Hematopoietic Stem and Progenitor Cell Activity Promotes Interleukin-23-Driven Chronic Intestinal Inflammation
by: Griseri, T, et al.
Published: (2012)

The Role of Interleukin-9 in Asthma
by: Hans-Peter Hauber, et al.
Published: (2005-01-01)

Interleukin 23 receptor and susceptibility to ankylosing spondylitis
by: Pointon, J, et al.
Published: (2008)

2349 The role of interleukin-23 in human melanoma
by: Aditi Jani, et al.
Published: (2018-06-01)

A Review of Interleukin-23/Interleukin-17 Inhibitor Exposure during Pregnancy in Patients with Psoriasis
by: Nirali Doshi, et al.
Published: (2024-10-01)

Analysis of Interleukin-17, Interleukin-23, neopterin and Nesfatin-1 levels in the sera of Hashimoto patients
by: Bayraktar Nihayet, et al.
Published: (2023-01-01)

Microglia and CNS Interleukin-1: Beyond Immunological Concepts
by: Xiaoyu Liu, et al.
Published: (2018-01-01)

Interleukin 10 is a growth factor for a population of regulatory T cells.
by: Asseman, C, et al.
Published: (1998)

Induction of Interleukin-10 expression by the commensal flora
by: Bollrath, J, et al.
Published: (2011)

Effects of interleukin-12/23 inhibitors and interleukin-17 inhibitors on myocardial functions in patients with severe psoriasis
by: Leyla Baykal Selçuk, et al.
Published: (2024-12-01)

Immunoexpression of Interleukin-22 and Interleukin-23 in Oral and Cutaneous Lichen Planus Lesions: A Preliminary Study
by: Jun Chen, et al.
Published: (2013-01-01)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
by: Cauli A, et al.
Published: (2015-10-01)

The Association between Vitamin D, Interleukin-4, and Interleukin-10 Levels and CD23+ Expression with Bronchial Asthma in Stunted Children
by: Gartika Sapartini, et al.
Published: (2023-09-01)

First Characterization of Chicken Interleukin-9
by: Shuangjiang He, et al.
Published: (2022-06-01)

The role of interleukin (IL)-23 in regulating pain in arthritis
by: Kevin M.-C. Lee, et al.
Published: (2022-04-01)

The role of Interleukin-23/Interleukin-17 axis in coexisting anti-glomerular basement membrane disease and lupus nephritis
by: Se Jin Park, et al.
Published: (2013-01-01)

Interleukin-23 Drives Intestinal Inflammation through Direct Activity on T Cells (vol 33, pg 279, 2010)
by: Ahern, P, et al.
Published: (2011)

Concentrations of matrix metallopeptidase 9, interleukin 4, and interleukin 8 in follicular fluid, and the results of fertilization
by: Rafał Adamczak, et al.
Published: (2022-09-01)

Increased interleukin-9 and Th9 cells in patients with refractory Graves’ disease and interleukin-9 polymorphisms are associated with autoimmune thyroid diseases
by: Qiuming Yao, et al.
Published: (2024-03-01)

Interleukin-21 and Interleukin-23 levels in familial Mediterranean Fever before and after treatment: the role of cytokines in disease pathogenesis
by: Mutlu Hizal, et al.
Published: (2024-09-01)

The role of interleukin-17 and interleukin-23 inhibitors in the development, progression, and recurrence of cancer: A systematic reviewCapsule Summary
by: Marie Vangilbergen, MD, et al.
Published: (2024-12-01)

Association Abnormal Levels of Serum Interleukin-33, Interleukin-23 with Oxidant-Antioxidants Status in patients with Acute Liver Failure
by: Auhood k. zaid, et al.
Published: (2022-12-01)